Denise Hélen Imaculada Pereira de Oliveira

Denise Hélen Imaculada Pereira de Oliveira

Auto-generated profile, based on publicly available information

Denise Hélen Imaculada Pereira de Oliveira

Universidade Federal do Ceará

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
MVMarcelo Gadelha Vasconcelos
Marcelo Gadelha Vasconcelos
RVRodrigo Gadelha Vasconcelos
Rodrigo Gadelha Vasconcelos
DODenise Hélen Imaculada Pereira de Oliveira
Denise Hélen Imaculada Pereira de Oliveira
ESEdilmar de Moura Santos
Edilmar de Moura Santos
LPLeão Pereira Pinto
Leão Pereira Pinto
LQLélia Maria Guedes Queiroz
Lélia Maria Guedes Queiroz

31 August 2018 in Oral Diseases
Verified
Journal Article
Open access
PDF file
DODenise Hélen Imaculada Pereira de Oliveira
Denise Hélen Imaculada Pereira de Oliveira
ÉSÉricka Janine Dantas da Silveira
Éricka Janine Dantas da Silveira
LSLélia Batista de Souza
Lélia Batista de Souza
CCClaudia Haydee S. Caro‐Sanchez
Claudia Haydee S. Caro‐Sanchez
HDHugo Dominguez‐Malagon
Hugo Dominguez‐Malagon
LQLélia Maria Guedes Queiroz
Lélia Maria Guedes Queiroz
Objective: To immunohistochemically characterize a group of oral myofibroblastic lesions (MLs) and to evaluate the ultrastructural features of myofibroblasts.Material and Methods: Using a tissue microarray technique (TMA), cases of myofibroma (MF), of nodular fasciitis (NF), of desmoplastic fibroma (DF), and of myofibroblastic sarcoma (MS) from the Universidad Autónoma Metropolitana Xochimilco, and a Private Oral Pathology Service in Mexico City were stained with antibodies against alpha‐smooth muscle actin (α‐SMA), H‐caldesmon, vimentin, desmin, β‐catenin, CD34, anaplastic lymphoma protein kinase (ALK‐1), and Ki‐67.Results: Nineteen of the 22 MF cases, 2/5 of the NF cases, 1/10 of the DF cases, and 1/2 of the MS cases were positive for α‐SMA. 1/2 of the MS cases were positive for desmin; 6/10 of the DF cases were positive for β‐catenin, and 2 of the MF cases were positive for ALK‐1. All of the MLs were positive for vimentin and negative for H‐caldesmon and CD‐34. The Ki‐67 labeling index in all of the 8/22 MF, 3/5 NF, and 2/2 MS cases was ≥10%. For all of the MLs evaluated, ultrastructural analysis revealed spindle‐shaped cells containing endoplasmic reticulum and peripheral actin filament bundles.Conclusion: In certain myofibroblastic lesions, the use of auxiliary techniques (such as immunohistochemistry) can be critical for differential diagnosis.

4 June 2013 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
PDF file
DODenise Hélen Imaculada Pereira de Oliveira
Denise Hélen Imaculada Pereira de Oliveira
ÉSÉricka Janine Dantas da Silveira
Éricka Janine Dantas da Silveira
AMAna Miryam Costa de Medeiros
Ana Miryam Costa de Medeiros
PAPollianna Muniz Alves
Pollianna Muniz Alves
LQLélia Maria Guedes Queiroz
Lélia Maria Guedes Queiroz

1 June 2015 in Jornal Vascular Brasileiro
Verified
Journal Article
Open access
PDF file
TFTiago João da Silva Filho
Tiago João da Silva Filho
DODenise Hélen Imaculada Pereira de Oliveira
Denise Hélen Imaculada Pereira de Oliveira
IMIlnara de Souza Moura
Ilnara de Souza Moura
LMLayssa Karolinne da Silva Medeiros
Layssa Karolinne da Silva Medeiros
AGAmanda Katarinny Goes Gonzaga
Amanda Katarinny Goes Gonzaga
LQLélia Maria Guedes Queiroz
Lélia Maria Guedes Queiroz
Vascular anomalies (VAs) include a group of distinct lesions, such as vascular system congenital malformations, as well as benign and malignant vascular tumors. These lesions may present similar clinical and histopathological features, leading to mistaken diagnoses and incorrect treatment choices. It is important that professionals responsible for monitoring the development of VAs conduct precise investigations and use the appropriate terminology. The human glucose transporter protein isoform 1 (GLUT1) has been proposed as a tool to aid in differential diagnosis between different VAs, given that it is a sensitive and specific marker for identification of infantile hemangiomas (HIs) in any organ. This article presents a review of the literature on this protein as an effective tool for identification and possible differential diagnosis between several VAs.

1 December 2016 in Archives of Oral Biology
Verified
Journal Article
Closed access
FNFernando Nóbrega
Fernando Nóbrega
DODenise Hélen Imaculada Pereira de Oliveira
Denise Hélen Imaculada Pereira de Oliveira
RVRodrigo Gadelha Vasconcelos
Rodrigo Gadelha Vasconcelos
CNCassiano Weege Nonaka
Cassiano Weege Nonaka
LQLélia Maria Guedes Queiroz
Lélia Maria Guedes Queiroz

1 December 2014 in Pathology - Research and Practice
Verified
Journal Article
Closed access
DODenise Hélen Imaculada Pereira de Oliveira
Denise Hélen Imaculada Pereira de Oliveira
AAAssis Filipe Medeiros Albuquerque
Assis Filipe Medeiros Albuquerque
MBMatheus Dantas de Araújo Barreto
Matheus Dantas de Araújo Barreto
CNCassiano Weege Nonaka
Cassiano Weege Nonaka
JSJose Sandro Pereira da Silva
Jose Sandro Pereira da Silva
LQLélia Maria Guedes Queiroz
Lélia Maria Guedes Queiroz